| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 6 717-723, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
JM Gudas, T Li, H Nguyen, D Jensen, FJ Rauscher 3rd and KH Cowan
Medicine Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.
BRCA1 was originally isolated as a gene that conferred susceptibility to early-onset familial breast and ovarian cancers. The function and regulation of this gene is presently unknown. Northern blot analyses using probes that recognize different regions of the BRCA1 cDNA revealed the presence of at least two distinct mRNA species. In synchronized normal and immortalized human mammary epithelial cells, BRCA1 mRNA levels were high in exponentially growing populations, decreased upon growth factor withdrawal, and subsequently increased again in late G1 just prior to S-phase entry. BRCA1 mRNA levels were found to be dramatically reduced in senescent normal human mammary epithelial cells and in normal human mammary epithelial cells treated with transforming growth factor beta 1. When considered together, these data indicate that expression of BRCA1 mRNA is highly sensitive to changes in growth conditions in vitro. BRCA1 proteins with apparent molecular weights of M(r) 210,000, 185,000, 160,000, 135,000, and 85,000, respectively, were detected at varying levels in all breast epithelial cells examined. Further molecular characterization of the nature and function of the different BRCA1 mRNAs and proteins should increase our understanding of this gene in the etiology of human breast cancers.
This article has been cited by other articles:
![]() |
R. S. Muraoka-Cook, L. S. Caskey, M. A. Sandahl, D. M. Hunter, C. Husted, K. E. Strunk, C. I. Sartor, W. A. Rearick Jr., W. McCall, M. K. Sgagias, et al. Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1. Mol. Cell. Biol., September 1, 2006; 26(17): 6412 - 6424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Hockings, P. A. Thorne, M. Q. Kemp, S. S. Morgan, O. Selmin, and D. F. Romagnolo The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen Cancer Res., February 15, 2006; 66(4): 2224 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, S. Fan, and E. M. Rosen Regulation of the Estrogen-Inducible Gene Expression Profile by the Breast Cancer Susceptibility Gene BRCA1 Endocrinology, April 1, 2005; 146(4): 2031 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Choudhury, H. Xu, and R. Baer Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Feng, L. Kachnic, J. Zhang, S. N. Powell, and F. Xia DNA Damage Induces p53-dependent BRCA1 Nuclear Export J. Biol. Chem., July 2, 2004; 279(27): 28574 - 28584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T I Orban and E Olah Emerging roles of BRCA1 alternative splicing Mol. Pathol., August 1, 2003; 56(4): 191 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thakur, T. Nakamura, G. Calin, A. Russo, J. F. Tamburrino, M. Shimizu, G. Baldassarre, S. Battista, A. Fusco, R. P. Wassell, et al. Regulation of BRCA1 Transcription by Specific Single-Stranded DNA Binding Factors Mol. Cell. Biol., June 1, 2003; 23(11): 3774 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Baldassarre, S. Battista, B. Belletti, S. Thakur, F. Pentimalli, F. Trapasso, M. Fedele, G. Pierantoni, C. M. Croce, and A. Fusco Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma Mol. Cell. Biol., April 1, 2003; 23(7): 2225 - 2238. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miralem and H. K. Avraham Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus Mol. Cell. Biol., January 15, 2003; 23(2): 579 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Huber, T. W. Yang, C. J. Sarkisian, S. R. Master, C.-X. Deng, and L. A. Chodosh Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci Mol. Cell. Biol., June 15, 2001; 21(12): 4005 - 4015. [Abstract] [Full Text] |
||||
![]() |
R. E. Buller, T. A. Lallas, M. S. Shahin, A. K. Sood, M. Hatterman-Zogg, B. Anderson, J. I. Sorosky, and P. A. Kirby The p53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer Clin. Cancer Res., April 1, 2001; 7(4): 831 - 838. [Abstract] [Full Text] |
||||
![]() |
S. Swami, A. V. Krishnan, and D. Feldman 1{{alpha}},25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells Clin. Cancer Res., August 1, 2000; 6(8): 3371 - 3379. [Abstract] [Full Text] |
||||
![]() |
A. Wang, R. Schneider-Broussard, A. P. Kumar, M. C. MacLeod, and D. G. Johnson Regulation of BRCA1 Expression by the Rb-E2F Pathway J. Biol. Chem., February 11, 2000; 275(6): 4532 - 4536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. LEE, K. COLLINS, A. BROWN, C.-H. LEE, and J.H. CHUNG The Function of BRCA1 in DNA Damage Response Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 547 - 552. [Abstract] [PDF] |
||||
![]() |
H. Kaji, L. Canaff, D. Goltzman, and G. N. Hendy Cell Cycle Regulation of Menin Expression Cancer Res., October 1, 1999; 59(20): 5097 - 5101. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. DÖRK, B. SKAWRAN, M. STUHRMANN, M. BREMER, and J. H KARSTENS BRCA1 expression is not affected by the intronic 12 bp duplication J. Med. Genet., March 1, 1999; 36(3): 262 - 263. [Full Text] |
||||
![]() |
L. Y. Marmorstein, T. Ouchi, and S. A. Aaronson The BRCA2 gene product functionally interacts with p53 and RAD51 PNAS, November 10, 1998; 95(23): 13869 - 13874. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-C. Hsu and R. L. White BRCA1 is associated with the centrosome during mitosis PNAS, October 27, 1998; 95(22): 12983 - 12988. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jin, X. L. Xu, M.-C. W. Yang, F. Wei, T.-C. Ayi, A. M. Bowcock, and R. Baer Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains PNAS, October 28, 1997; 94(22): 12075 - 12080. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ruffner and I. M. Verma BRCA1 is a cell cycle-regulated nuclear phosphoprotein PNAS, July 8, 1997; 94(14): 7138 - 7143. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Ludwig, D L Chapman, V E Papaioannou, and A Efstratiadis Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes & Dev., May 15, 1997; 11(10): 1226 - 1241. [Abstract] [PDF] |
||||
![]() |
J. E. Thomas, M. Smith, B. Rubinfeld, M. Gutowski, R. P. Beckmann, and P. Polakis Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1 J. Biol. Chem., November 8, 1996; 271(45): 28630 - 28635. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Smith, M K Lee, C I Szabo, N Jerome, M McEuen, M Taylor, L Hood, and M C King Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res., November 1, 1996; 6(11): 1029 - 1049. [Abstract] [PDF] |
||||
![]() |
C. J. Sarkisian, S. R. Master, L. J. Huber, S. I. Ha, and L. A. Chodosh Analysis of Murine Brca2 Reveals Conservation of Protein-Protein Interactions but Differences in Nuclear Localization Signals J. Biol. Chem., September 28, 2001; 276(40): 37640 - 37648. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu and R. Baer Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor J. Biol. Chem., June 9, 2000; 275(24): 18541 - 18549. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |